Article Figures & Data
Figures
- Fig 1.
Flow diagram of the study-selection process.
- Fig 2.
Coupled forest plots of the pooled sensitivity and specificity for the diagnostic performance of MR imaging for prediction of MGMT promoter methylation in patients with newly diagnosed glioblastoma. Numbers are pooled estimates with 95% confidence intervals in parentheses and horizontal lines indicating 95% CIs.
Jump to section
Related Articles
Cited By...
- Unravelling the Impact of Tumor Location on Patient Survival in Glioblastoma: A Genomics and Radiomics Approach
- MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation Status
- MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features
- MRI-BASED DEEP LEARNING METHOD FOR DETERMINING METHYLATION STATUS OF THE O6-METHYLGUANINE-DNA METHYLTRANSFERASE PROMOTER OUTPERFORMS TISSUE BASED METHODS IN BRAIN GLIOMAS